About

Truveris operates in the prescription drug industry, focusing on the pharmacy supply chain to simplify its complexities. The company provides technology and data analytics solutions to various clients, including payers, brokers, and pharmaceutical manufacturers. Their services include cost containment strategies, clinical guidance, and custom-branded pharmacy practice programs that help benefits advisors enhance their offerings. Truveris also develops patient access programs to assist pharmaceutical brands in effectively reaching patients and adapting to market changes. A key aspect of their work involves addressing regulatory challenges, ensuring clients can navigate issues like product recalls. The goal of Truveris is to deliver clear insights into pharmacy benefits, ultimately improving employee health, productivity, and satisfaction.

Simplify's Take

What believers are saying

• Truveris raised $15M in Series E funding for corporate development and growth.
• The company launched oneRx, enhancing member-centric patient engagement solutions.
• Truveris' leadership appointments strengthen its commercial and operational strategies.

What critics are saying

• Increased competition from Amazon Pharmacy threatens Truveris' market share.
• Direct-to-consumer pharmaceutical sales models may bypass traditional pharmacy benefit managers.
• Potential regulatory changes could affect Truveris' pricing strategies.

What makes Truveris unique

• Truveris offers a transparent platform replacing traditional pharmacy benefit manager models.
• The company provides ongoing analysis of 100% of claims for contract compliance.
• Truveris collaborates with Mark Cuban Cost Plus Drug Company to reduce pharmacy benefits spend.

Help us improve and share your feedback! Did you find this helpful?

YesNo